-
1دورية أكاديمية
المؤلفون: Annalisa Adamo, Cristina Frusteri, Sara Pilotto, Simone Caligola, Lorenzo Belluomini, Ornella Poffe, Luca Giacobazzi, Silvia Dusi, Chiara Musiu, Yushu Hu, Tian Wang, Davide Rizzini, Antonio Vella, Stefania Canè, Giulia Sartori, Jessica Insolda, Marco Sposito, Ursula Cesta Incani, Carmine Carbone, Geny Piro, Francesca Pettinella, Fang Qi, Dali Wang, Silvia Sartoris, Francesco De Sanctis, Patrizia Scapini, Stefano Dusi, Marco Antonio Cassatella, Emilio Bria, Michele Milella, Vincenzo Bronte, Stefano Ugel
المصدر: OncoImmunology, Vol 12, Iss 1 (2023)
مصطلحات موضوعية: NSCLC (non-small cell lung cancer), M-MDSCs (monocytic myeloid-derived suppressor cells), c-FLIP (cellular FLICE [FADD-like IL-1β-converting enzyme]- inhibitory protein), ICI (immune checkpoint inhibitor), Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2162-402XTest
-
2دورية أكاديمية
المؤلفون: Lin Liang, Chanjuan Cui, Dan Lv, Yiqun Li, Liyan Huang, Jiayu Feng, Tao An, Pengchao Tian, Ke Yang, Linjun Hu, Lizhen Gao, Jian Zhang, Yuhui Zhang, Fei Ma, Yanfeng Wang
المصدر: ESC Heart Failure, Vol 10, Iss 3, Pp 1907-1918 (2023)
مصطلحات موضوعية: ICI, immune checkpoint inhibitor, iRC, immune checkpoint inhibitor‐related cardiotoxicity, Inflammatory biomarkers, NER, neutrophil‐to‐eosinophil ratio, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2055-5822Test
-
3
المؤلفون: Richmond M. Castillo, Uma Thanarajasingam, Michael D. Richter, Benjamin J. Sandefur, Alexander S. Finch
المصدر: Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 6, Pp 1029-1035 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomesمصطلحات موضوعية: medicine.medical_specialty, Medicine (General), EM, emergency medicine, business.industry, Brief Report, ICI, immune checkpoint inhibitor, Immune checkpoint inhibitors, EMR, electronic medical record, Cancer, Emergency department, medicine.disease, Tertiary care, irAE, immune-related adverse effect, R5-920, Baseline characteristics, Emergency medicine, Cohort, Medicine, ED, emergency department, Differential diagnosis, Adverse effect, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46dc22bc1189b269f429040b12db2493Test
http://www.sciencedirect.com/science/article/pii/S2542454821001508Test -
4
المؤلفون: Alexander Hapfelmeier, Sebastian Foersch, Siranush Karapetyan, Daniel-Christoph Wagner, Katja Steiger, Kristina Schwamborn, Marion Kiechle, Wilko Weichert, Wilfried Roth, Dirk Oettler, Aurelia Noske
المصدر: Breast, Vol 60, Iss, Pp 238-244 (2021)
The Breast : Official Journal of the European Society of Mastologyمصطلحات موضوعية: Oncology, CPS, combined positive score, TC, tumor cells, ICI, immune checkpoint inhibitor, Triple Negative Breast Neoplasms, B7-H1 Antigen, Medicine, HER2, human epidermal growth factor receptor 2, Triple-negative breast cancer, RC254-282, ICC, intraclass correlation coefficient, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, MSI, microsatellite instability, Immunohistochemistry, pCR, pathological complete response, PFS, progression-free survival, Original Article, IC-Score, IC, immune cells, IHC, immunohistochemistry, Programmed death, PD-L1, medicine.medical_specialty, Concordance, TNBC, triple-negative breast cancer, OS, overall survival, Breast cancer, Internal medicine, TPS, tumor proportion score, Biomarkers, Tumor, Humans, Programmed death-ligand 1, Reproducibility, business.industry, Reproducibility of Results, medicine.disease, ITT, intention to treat, CI, confidence interval, PD-L1, programmed death-ligand 1, biology.protein, Surgery, CPS, business, Kappa, TMB, tumor mutational burden
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a50b5eac3f8c4ff158e8c3f6dfcb0cTest
http://www.sciencedirect.com/science/article/pii/S0960977621009851Test -
5
المؤلفون: Hao Wang, Lei Wang, Keyi Jia, Yu Liu, Sha Zhao, Wei Li, Caicun Zhou, Minlin Jiang, Bin Chen, Yayi He
المصدر: Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 10, Pp 2983-2994 (2021)مصطلحات موضوعية: Genome instability, PD-L1, programmed death ligand 1, BRCA, breast cancer susceptibility gene, ICI, immune checkpoint inhibitor, medicine.medical_treatment, MUTYH, MutY homolog, cGAS, cyclic GMP–AMP synthase, Review, DNA damage response, Malignant transformation, ORR, objective response rate, PCR, polymerase chain reaction, 0302 clinical medicine, SCNAs, somatic copy number alterations, FDA, United State Food and Drug Administration, Cancer immunotherapy, MGMT, O6-methylguanine methyltransferase, PD-1, RB1, retinoblastoma 1, General Pharmacology, Toxicology and Pharmaceutics, BER, base excision repair, RAD51C, RAD51 homolog C, 0303 health sciences, TME, tumor microenvironment, TP53, tumor protein P53, cGAS–STING, MSI, microsatellite instability, TRIF, Toll-interleukin 1 receptor domain-containing adaptor inducing INF-β, PFS, progression-free survival, STAT, signal transducer and activator of transcription, NEK1, NIMA-related kinase 1, Tumor microenvironment, PALB2, partner and localizer of BRCA2, RSR, replication stress response, 030220 oncology & carcinogenesis, Immunotherapy, PARP, poly-ADP ribose polymerase, JAK, Janus kinase, IHC, immunohistochemistry, Genomic instability, PD-L1, DSBs, double-strand breaks, DNA repair, DNA damage, CHK1, checkpoint kinase 1, IRF1, interferon regulatory factor 1, MLH1, MutL homolog 1, RM1-950, MMR, mismatch repair, STING, stimulator of interferon genes, Biology, MNT, MAX network transcriptional repressor, DDR, DNA damage response, MSH2/6, MutS protein homologue-2/6, OS, overall survival, RPA, replication protein A, 03 medical and health sciences, GSK3β, glycogen synthase kinase 3β, NER, nucleotide excision repair, NSCLC, non-small cell lung cancer, MyD88, myeloid differentiation factor 88, ssDNA, single-stranded DNA, medicine, DAMP, damage-associated molecular patterns, DR, direct repair, 030304 developmental biology, BAP1, BRCA1-associated protein 1, BRAF, v-RAF murine sarcoma viral oncogene homologue B, TLR4, Toll-like receptor 4, Cancer, NGS, next generation sequencing, ATM, ataxia-telangiectasia mutated, NIMA, never-in-mitosis A, medicine.disease, CHEK, cell-cycle checkpoint kinase, PD-1, programmed death 1, MAD1, mitotic arrest deficient-like 1, body regions, IFNγ, interferon gamma, TILs, tumor-infiltrating lymphocytes, TBK1, TANK-binding kinase 1, ATR, ataxia telangiectasia and Rad3 related, Cancer research, NHEJ, nonhomologous end-joining, Therapeutics. Pharmacology, HMGB1, high mobility group box-1, HRR, homologous recombination repair, XRCC4, X-ray repair cross complementing protein 4, TMB, tumor mutational burden
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe73202674a833d134ec811bcbf7332Test
https://doi.org/10.1016/j.apsb.2021.01.003Test -
6
المؤلفون: C. Dutriaux, N. Andreu, Anne Pham-Ledard, Thomas Barnetche, Léa Dousset, Alize Pacaud, Katia Boniface, Marie Kostine, Julien Seneschal, S. Prey, Marie Beylot-Barry, Emilie Gérard
المصدر: JAAD International
JAAD International, Vol 5, Iss, Pp 112-120 (2021)مصطلحات موضوعية: Oncology, vitiligo, medicine.medical_specialty, Skin Neoplasms, Cross-sectional study, ICI, immune checkpoint inhibitor, Dermatology, Vitiligo, halo phenomenon around cutaneous metastases, OS, overall survival, Internal medicine, medicine, melanoma, Humans, Progression-free survival, skin and connective tissue diseases, integumentary system, Cell Death, business.industry, Proportional hazards model, Hazard ratio, Odds ratio, PD-1, programmed cell death-1, medicine.disease, leukotrichia, aHR, adjusted hazard ratio, PFS, progression-free survival, OR, odds ratio, RL1-803, Cohort, Original Article, immunotherapy, business, checkpoint inhibitors, Cohort study, irAE, immune-related adverse event
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69bcb43d0fbbda6967f5f3f22a3c148Test
http://europepmc.org/articles/PMC8529074Test -
7
المؤلفون: Naoya Yamazaki, Mana Ishibashi, Kazuhiro Kitajima, Tadashi Watabe, Atsushi Tanemura, Fumihiko Soeda, Hiromitsu Daisaki, Kimiteru Ito, Masatoyo Nakajo, Takuro Kanekura
المصدر: Japanese Journal of Radiology
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Concordance, medicine.medical_treatment, Standardized uptake value, Pembrolizumab, Progressive Metabolic Disease, EORTC (European Organization for Research and Treatment of Cancer), 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Immune Checkpoint Inhibitors, Melanoma, Malignant melanoma, PERCIST (Positron Emission Tomography Response Criteria in Solid Tumors), business.industry, Cancer, PET/CT (positron emission tomography/computed tomography), Prognosis, medicine.disease, FDG (fluorodeoxyglucose), Radiation therapy, Treatment Outcome, 030220 oncology & carcinogenesis, Original Article, ICI (immune checkpoint inhibitor), Nivolumab, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b4840ac12c0dd86324f39f84522c98Test
https://doi.org/10.1007/s11604-021-01174-wTest -
8
المؤلفون: Anne Y. Liu, Jasmine Rana, Lisa C. Zaba, Kerri E. Rieger, Nolan J. Maloney, Bernice Y. Kwong, Silvina Pugliese, Jenna Strelo
المصدر: JAAD Case Reports
JAAD Case Reports, Vol 13, Iss, Pp 147-151 (2021)مصطلحات موضوعية: BRAF inhibitor, PD-L1, ICI, immune checkpoint inhibitor, medicine.medical_treatment, BRAFi, BRAF inhibitors, immune related adverse effect, encorafenib, rash, Dermatology, BRAF, Targeted therapy, irAE, PD-1, DIHS, drug-induced hypersensitivity syndrome, medicine, Case Series, dabrafenib, Vemurafenib, CTLA4, ICI, Angioedema, biology, business.industry, Dabrafenib, DIHS, oncoderm, Rash, DLR, DIHS-like reaction, Immune checkpoint, immune checkpoint therapy, PD1, Antecedent (behavioral psychology), TT, targeted therapy, RL1-803, Immunology, biology.protein, vemurafenib, medicine.symptom, DRESS, business, ircAE, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8412a11862a80bb2b06a166951ad24efTest
https://doi.org/10.1016/j.jdcr.2021.04.033Test -
9
المؤلفون: Espinosa Arranz Enrique, Ander Mayor Ibarguren, Custodio Ana, Peiteado Lopez Diana, Herranz Pinto Pedro
المصدر: JAAD Case Reports, Vol 11, Iss, Pp 84-89 (2021)
JAAD Case Reportsمصطلحات موضوعية: PGA, physician's global assessment, medicine.medical_specialty, pSA, psoriatic arthritis, ICI, immune checkpoint inhibitor, BSA, body surface area, apremilast, Ipilimumab, Pembrolizumab, Dermatology, supportive dermato-oncology, PDE-4 inhibitors, Acitretin, PD-1, programmed cell death protein 1, immune checkpoint inhibitors, Psoriatic arthritis, Antineoplastic Agents, Immunological, Psoriasis, medicine, Maculopapular rash, Humans, Case Series, irAE, immune-related adverse events, PDL-1, programmed death-ligand 1, anti-pd1, nivolumab, business.industry, PASI, psoriasis area severity index, psoriasis, immune-induced psoriasis, medicine.disease, RL1-803, PFS, progression free survival, immune-related adverse events, Apremilast, medicine.symptom, Nivolumab, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da909d0442c3f1ab371ccb01087764eTest
http://www.sciencedirect.com/science/article/pii/S2352512621001806Test -
10
المؤلفون: Chi Ma, Benjamin L. Green, Benjamin Ruf, Mayank Tandon, Laurence P. Diggs, John C. McVey, Simon Wabitsch, Bernd Heinrich, Tim F. Greten, Qianfei Zhang, Justin D. McCallen
المصدر: Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 3, Pp 1166-1178 (2021)مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, ICI, immune checkpoint inhibitor, Programmed Cell Death 1 Receptor, IC50, median inhibitory concentration, RC799-869, medicine.disease_cause, WES, whole-exome sequencing, Cholangiocarcinoma, Mice, 0302 clinical medicine, iCCA, intrahepatic cholangiocarcinoma, Immune Checkpoint Inhibitors, Original Research, Trametinib, medicine.diagnostic_test, Gastroenterology, High-Throughput Nucleotide Sequencing, Drug Synergism, Diseases of the digestive system. Gastroenterology, Anti–PD-1 Monoclonal Antibody, Editorial, Female, 030211 gastroenterology & hepatology, KRAS, Immunotherapy, Combination therapy, Cell Survival, Pyridones, PD-L1, programmed cell death ligand 1, PBS, phosphate-buffered saline, IFNγ, interferon γ, Pyrimidinones, MHC-1, major histocompatibility complex, Flow cytometry, PD-1, programmed cell death protein 1, 03 medical and health sciences, Cell Line, Tumor, Exome Sequencing, medicine, Animals, Humans, Cell Proliferation, Mitogen-Activated Protein Kinase Kinases, Tumor microenvironment, Hepatology, Cell growth, business.industry, KRASwt, KRAS wild-type, Xenograft Model Antitumor Assays, 030104 developmental biology, Bile Ducts, Intrahepatic, Bile Duct Neoplasms, Cancer research, Intrahepatic Cholangiocarcinoma, business, CD8
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfa0235fd2025edb0051c54423904e0Test
http://europepmc.org/articles/PMC8413239Test